Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: A 12-month prospective uncontrolled study

American Journal of Kidney Diseases

Volumn 57, Issue 6, 2011, Pages 961-963

  De Nicola, Luca ^a   Zamboli, Pasquale ^a   Bellizzi, Vincenzo ^b   Stanzione, Giovanna ^a   Russo, Domenico ^c   Nappi, Felice ^d   Minco, Maristella ^c   Chiodini, Paolo ^a   Conte, Giuseppe ^a   Minutolo, Roberto ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b S Giovanni di Dio   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d S Maria della Piet Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM; SODIUM;

ADD ON THERAPY; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIZZINESS; DRUG EFFECT; DRUG SAFETY; FATIGUE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; HYPOTENSION; LETTER; POTASSIUM BLOOD LEVEL; PROSPECTIVE STUDY; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SIDE EFFECT; SODIUM EXCRETION;

AMIDES; FOLLOW-UP STUDIES; FUMARATES; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME;

EID: 79956367925     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.02.384     Document Type: Letter

References (10)

1. G. Remuzzi, A. Benigni, and A. Remuzzi Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes J Clin Invest 116 2006 288 296 (Pubitemid 43228342)
2. D.N. Mller, and F.C. Luft Direct renin inhibition with aliskiren in hypertension and target organ damage Clin J Am Soc Nephrol 1 2006 221 228
3. F. Catapano, P. Chiodini, and L. De Nicola Antiproteinuric response to dual blockade of RAS in primary glomerulonephritis: meta-analysis and meta-regression Am J Kidney Dis 52 2008 475 485
4. R. Kunz, C. Friedrich, and M. Wolbers Metaanalysis: effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease Ann Intern Med 148 2008 30 48 (Pubitemid 351688350)
5. P. Ruggenenti, A. Perna, G. Remuzzi GISEN Group Investigators Retarding progression of chronic renal disease: the neglected issue of residual proteinuria Kidney Int 63 2003 2254 2261 (Pubitemid 36605839)
6. H.H. Parving, F. Persson, J.B. Lewis, E.J. Lewis, N.K. Hollenberg AVOID Study Investigators Aliskiren combined with losartan in type 2 diabetes and nephropathy N Engl J Med 358 2008 2433 2446 (Pubitemid 351793017)
7. F. Persson, P. Rossing, and H. Reinhard Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria Diabetes Care 32 2009 1873 1879
8. A.D. Rule, H. Amer, and L.D. Cornell The association between age and nephrosclerosis on renal biopsy among healthy adults Ann Intern Med 152 2010 561 567
9. D. de Zeeuw, R. Agarwal, and M. Amdahl Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL Study): a randomised controlled trial Lancet 376 2010 1543 1551
10. L. De Nicola, R. Minutolo, P. Chiodini TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention Kidney Int 69 2006 538 545 (Pubitemid 43164447)